Senti Biosciences, Inc.
- SNTI
- NASDAQ
- Biotechnology
- Gene Circuit Technology
- Cell & Gene Therapy
$0.23
Today +0.84%Quote Oct 19, 2026, 08:00 PM UTC
−29.13%over the last month
Max drawdown −34.8%From 1-month high −34.3%3 months −50.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Senti Biosciences
Senti Biosciences, Inc. is a pioneering company specializing in gene circuit technology. They focus on creating advanced cell and gene therapies that incorporate sophisticated gene circuits, essentially biological computers, to genetically reprogram cells.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
39
Market value
$7.1M
Quote Oct 19
Analyst target
$6.00
+2545.5% from here
Floor
$0.18
18.9% below price
Resistance
$0.25
11.6% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SNTIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free